Weekly Watchlist: Vaccines Gain Ground; the Fight to Fix Political Polling

Greetings, Quicktake readers! This week, we're discussing the vaccine frontrunners as the U.S. marks a grim pandemic milestone. Then: the key to diversifying top jobs. Stream now.

Experimental Covid-19 vaccines from Pfizer and Moderna may be nearing the finish line after new data showed they were 95% and 94.5% effective, a dose of optimism as virus cases soar in the U.S. and around the world. Pfizer plans to seek emergency authorization from the FDA within days. "For the last nine months, we've been absolutely ground down by wearing masks and staying indoors," Dr. Gabor Kelen of Johns Hopkins University told Quicktake anchor Tim Stenovec on Take Charge.